In vivo exposure of the bladder using a non-invasive high intensity focused ultrasound toroidal transducer

Victor Delattre,Sophie Cambronero,Yao Chen,Gail Ter Haar,Ian Rivens,Gerry Polton,Cyril Lafon,David Melodelima

DOI: https://doi.org/10.1016/j.ultras.2024.107239

2024-01-19

Abstract:A toroidal high-intensity focused ultrasound (HIFU) transducer was used to expose normal bladder wall tissues non-invasively in vivo in a porcine model in order to investigate the potential to treat bladder tumors. The transducer was divided into 32 concentric rings with equal surface areas, operating at 2.5 MHz. Eight animals were split into two groups of 4. In the first group, post-mortem evaluation was performed immediately after ultrasound exposure. In the second group, animals survived for up to seven days before post-mortem evaluation. The ultrasound imaging guided HIFU device was hand-held during the procedure using optical tracking to ensure correct targeting. One thermal lesion in each animal was created using a 40 s exposure at 80 acoustic Watts (free-field) in the trigone region of the bladder wall. The average ($\pm$Standard Deviation) abdominal wall and bladder wall thicknesses were 10.3 $\pm$ 1.4 mm and 1.1 $\pm$ 0.4 mm respectively. The longest and shortest axes of the HIFU ablations were 7.7 $\pm$ 2.9 mm and 6.0 $\pm$ 1.8 mm, respectively, resulting in an ablation of the whole thickness of the bladder wall in most cases. Ablation were performed at an average depth (distance from the skin surface to the centre of the HIFU lesion) of 42.5 $\pm$ 3.8 mm and extended throughout the thickness of the bladder. There were two cases of injury to tissues immediately adjacent to the bladder wall but without signs of perforation, as confirmed by histological analysis. Non-invasive HIFU ablation using a hand-held toroidal transducer was successfully performed to destroy regions of the bladder wall in vivo.

Medical Physics

What problem does this paper attempt to address?

This paper aims to explore the feasibility of using non-invasive high-intensity focused ultrasound (HIFU) technology to treat the bladder wall in vivo, particularly for the treatment of bladder tumors. The study utilized a special annular HIFU transducer and conducted experiments on a pig model to evaluate its ability to ablate specific areas of the bladder wall, while also examining the safety and potential side effects of the technology.

Specifically, the paper attempts to address the following key issues:
1. **Technical Feasibility**: Verify whether the annular HIFU transducer can successfully perform thermal ablation of the bladder wall in vivo under non-invasive conditions.
2. **Safety**: Assess the impact of HIFU treatment on surrounding tissues, particularly whether there is damage to the skin, fat, or muscle layers, and whether there is a risk of bladder perforation.
3. **Efficacy Evaluation**: Confirm the pathological changes in the bladder wall after HIFU treatment, including the size, shape, and depth of the lesions.
4. **Long-term Effects**: Observe the short-term (immediate) and long-term (7 days later) effects after HIFU treatment to ensure that the treatment does not cause long-term adverse reactions or complications.

Through these studies, the authors hope to provide theoretical basis and technical support for the future clinical application of HIFU technology in the treatment of human bladder cancer.